| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11309 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10215 | 2012 |
| Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 3055 | 2017 |
| Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 2479 | 2017 |
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 JA Salomon, T Vos, DR Hogan, M Gagnon, M Naghavi, A Mokdad, ... The Lancet 380 (9859), 2129-2143, 2012 | 1562 | 2012 |
| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1278 | 2021 |
| The lancet global health commission on global eye health: vision beyond 2020 MJ Burton, J Ramke, AP Marques, RRA Bourne, N Congdon, I Jones, ... The Lancet Global Health 9 (4), e489-e551, 2021 | 824 | 2021 |
| UK health performance: findings of the Global Burden of Disease Study 2010 CJL Murray, MA Richards, JN Newton, KA Fenton, HR Anderson, ... The lancet 381 (9871), 997-1020, 2013 | 716 | 2013 |
| Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ... The Lancet global health 9 (2), e130-e143, 2021 | 637 | 2021 |
| Potential lost productivity resulting from the global burden of uncorrected refractive error TST Smith, KD Frick, BA Holden, TR Fricke, KS Naidoo Bulletin of the World Health Organization 87 (6), 431-437, 2009 | 471 | 2009 |
| Anti‐vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion T Braithwaite, AA Nanji, K Lindsley, PB Greenberg Cochrane Database of Systematic Reviews, 2014 | 179 | 2014 |
| Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... Lancet Glob Health 5 (12), e1221-e1234, 2017 | 177 | 2017 |
| The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice T Braithwaite, M Calvert, A Gray, K Pesudovs, AK Denniston Patient related outcome measures, 9-24, 2019 | 121 | 2019 |
| Vision Loss Expert Group. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and … RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... Lancet Glob Health 5 (9), e888-e897, 2017 | 108 | 2017 |
| New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study R Bourne, H Price, H Taylor, J Leasher, J Keeffe, J Glanville, PC Sieving, ... Ophthalmic epidemiology 20 (1), 33-39, 2013 | 91 | 2013 |
| Autoimmune retinopathy T Braithwaite, A Vugler, A Tufail Ophthalmologica 228 (3), 131-142, 2012 | 90 | 2012 |
| Global Prevalence of Blindness and Distance and Near Vision Impairment in 2020: progress towards the Vision 2020 targets and what the future holds. RRA Bourne, J Adelson, S Flaxman, P Briant, M Bottone, T Vos, K Naidoo, ... Investigative Ophthalmology & Visual Science 61 (7), 2317-2317, 2020 | 61 | 2020 |
| Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease T Braithwaite, A Subramanian, A Petzold, J Galloway, NJ Adderley, ... JAMA neurology 77 (12), 1514-1523, 2020 | 52 | 2020 |
| Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections CY Cheng, N Wang, TY Wong, N Congdon, M He, YX Wang, ... British Journal of Ophthalmology 104 (5), 616-622, 2020 | 51 | 2020 |
| Diagnostic features of the autoimmune retinopathies T Braithwaite, GE Holder, RWJ Lee, GT Plant, A Tufail Autoimmunity Reviews 13 (4-5), 534-538, 2014 | 51 | 2014 |
